10-Q: Flexible Solutions Q2 Net Income Jumps 57% on R&D Boost
Quarterly Report
Flexible Solutions International Inc. reported a significant increase in Q2 net income driven by new research and development service revenue, despite a decline in product sales.
Summary
- Net income attributable to Flexible Solutions International Inc. for the three months ended June 30, 2025, increased by 57.31% to $2,028,912, up from $1,289,796 in the prior year period.
- Total sales for the three months ended June 30, 2025, rose by 7.96% to $11,367,132, primarily due to $2,500,000 in research and development services revenue.
- Product sales for the three months ended June 30, 2025, decreased by 15.78% to $8,867,132 compared to $10,528,739 in the same period last year.
- Gross profit for the three months ended June 30, 2025, increased by 36.71% to $5,385,266, with the gross profit percentage improving due to the new R&D sales.
- For the six months ended June 30, 2025, net income attributable to Flexible Solutions International Inc. remained relatively flat at $1,751,178, a slight increase of 0.24% from $1,747,022 in the prior year.
- Total sales for the six months ended June 30, 2025, decreased by 4.62% to $18,840,824, as the $2,500,000 R&D services revenue partially offset a 17.28% decline in product sales.
- Working capital as of June 30, 2025, was $21,940,799, a decrease from $22,714,190 at December 31, 2024.
- Cash provided by operating activities for the six months ended June 30, 2025, decreased to $4,738,637 from $5,309,855 in the prior year.
- The company paid a special dividend of $0.10 per share, totaling $1,274,753, in May 2025.
Sentiment
Score: 7
Explanation: The significant increase in Q2 net income and gross profit, driven by a new R&D services project, is a strong positive. However, the underlying product sales decline and the overall flat net income for the six-month period, coupled with increased interest expense and decreased operating cash flow, present a mixed picture. The new R&D revenue stream is promising but its sustainability and ability to fully offset product sales weakness need to be monitored.
Positives
- Net income attributable to Flexible Solutions International Inc. increased by 57.31% for the three months ended June 30, 2025, reaching $2,028,912.
- Total sales for the three months ended June 30, 2025, increased by 7.96% to $11,367,132, primarily driven by a new $2,500,000 research and development services project.
- Gross profit for the three months ended June 30, 2025, significantly increased by 36.71% to $5,385,266, indicating improved profitability per sale.
- Operating income for the three months ended June 30, 2025, rose by 67.29% to $3,297,114.
- Reduced reliance on consultants, with consulting expenses decreasing to $41,127 for the three months and $142,077 for the six months ended June 30, 2025.
- Management asserts sufficient cash resources to meet future commitments and cash flow requirements for the coming year.
- Disclosure controls and procedures were evaluated as effective as of June 30, 2025, with no material changes in internal control over financial reporting.
Negatives
- Product sales decreased by 15.78% for the three months ended June 30, 2025, and by 17.28% for the six months ended June 30, 2025, due to decreased customer orders.
- Total sales for the six months ended June 30, 2025, decreased by 4.62% to $18,840,824.
- Net income for the six months ended June 30, 2025, decreased by 3.46% to $1,881,193.
- Cash provided by operating activities for the six months ended June 30, 2025, decreased by $571,218 to $4,738,637.
- Working capital decreased to $21,940,799 at June 30, 2025, from $22,714,190 at December 31, 2024.
- Interest expense increased for both the three-month ($184,126 vs $157,131) and six-month ($382,145 vs $332,397) periods due to increased debt.
- Gain on investment decreased significantly due to the sale of a 30.1% interest in a profitable Florida-based LLC in 2024.
- Utilities expense increased due to the addition of real estate not yet leased.
- Interest income decreased due to a decrease in term deposits held.
Risks
- Increased competitive pressures from existing competitors and new entrants.
- Increases in interest rates or the cost of borrowing, or a default under any material debt agreement.
- Deterioration in general or regional economic conditions.
- Adverse state or federal legislation or regulation that increases compliance costs, or adverse findings by a regulator.
- Loss of customers or sales weakness.
- Inability to achieve future sales levels or other operating results.
- The unavailability of funds for capital expenditures.
- Operational inefficiencies in distribution or other systems.
- New tariffs relating to raw materials imported from China.
- Fluctuations in the sale price of crude oil, which impacts the cost of aspartic acid (a key ingredient in TPA products).
- Activity in the oil and gas industry, as TPA products are sold to these companies.
- Drought conditions, as TPA products are sold to farmers.
Future Outlook
Management anticipates the market vertical for custom food and nutritional materials will grow over time. The company expects to expand disclosures regarding income taxes in the annual financial statements for the year ended December 31, 2025, following the adoption of ASU 2023-09. The company is evaluating the impact of ASU 2024-03 on its consolidated financial statements and disclosures, effective for annual periods beginning after December 15, 2026.
Management Comments
- We do not intend, and undertake no obligation, to update any forward-looking statement.
- Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements.
- The Company has sufficient cash resources to meets its future commitments and cash flow requirements for the coming year.
- Other than the foregoing we do not know of any trends, events or uncertainties that have had, or are reasonably expected to have, a material impact on our revenues or expenses.
- Other than as disclosed above, the Company does not anticipate any significant capital requirements for the twelve months ending June 30, 2026.
- Other than as disclosed above, the Company does not know of any trends, demands, commitments, events or uncertainties that will result in, or that are reasonable likely to result in, its liquidity increasing or decreasing in any material way.
Industry Context
The company operates in specialty chemicals, including water conservation products (swimming pools, irrigation) and biodegradable polymers (TPAs) for oil & gas, agriculture (fertilizer enhancement, nitrogen conservation), and consumer care. The decline in product sales suggests potential headwinds in traditional markets, possibly due to competitive pressures or market demand shifts. The new R&D services revenue indicates a strategic pivot or expansion into higher-value, custom solutions, which could be a response to evolving industry needs or a diversification strategy. The mention of crude oil prices, oil & gas activity, and drought conditions highlights the company's sensitivity to commodity markets and environmental factors, particularly for its TPA division.
Comparison to Industry Standards
- The filing does not provide specific industry benchmarks or comparable company data to assess performance against global standards.
- The company's gross profit percentage improvement, driven by R&D services, suggests a move towards higher-margin activities, which could be a positive differentiator if sustainable.
- The decline in product sales, while offset by R&D services, warrants closer examination against industry growth rates for specialty chemicals and agricultural inputs.
- The company's debt levels and interest expenses should be compared to industry averages to assess financial leverage and cost of capital.
Related Party Transactions
- Sales to the Florida-based LLC (an equity method investment) were $2,072,180 for the three months and $3,928,575 for the six months ended June 30, 2025.
- Accounts receivable from the Florida-based LLC were $1,978,433 as of June 30, 2025.
- Sales to the non-controlling interest (NCI) in ENP Investments were $1,094,243 for the three months and $1,924,726 for the six months ended June 30, 2025.
- Accounts receivable from the NCI in ENP Investments were $139,563 as of June 30, 2025.
- NanoChem (a wholly-owned subsidiary) is a guarantor of 65% of ENP Investments' line of credit, not to exceed $3,250,000. The non-controlling interest is the guarantor of the remaining 35%, not to exceed $1,750,000.
Stakeholder Impact
- Shareholders: Benefited from a special dividend of $0.10 per share. Net income per share increased for Q2, but diluted EPS for H1 slightly decreased. The shift to R&D services could indicate a strategic move for long-term value.
- Customers: Product sales declined, indicating potential reduced demand or competitive losses for existing products. New R&D services customer (Company E) represents a significant new revenue stream.
- Employees/Consultants: Decreased reliance on consultants suggests potential internalizing of some functions or reduced project-based work. Stock-based compensation is a component of employee benefits.
- Creditors: The company has substantial long-term debt and lines of credit, primarily with Stock Yards Bank and Trust. Repayments of short-term lines of credit and long-term debt are ongoing.
Next Steps
- Continue to sell the remaining 19.9% interest in the Florida-based LLC over the next five years, with annual $800,000 payments starting in 2025.
- Expand income tax disclosures in the annual financial statements for the year ended December 31, 2025, following the adoption of ASU 2023-09.
- Evaluate the impact of ASU 2024-03 on consolidated financial statements and disclosures, with new disclosure requirements effective for annual periods beginning after December 15, 2026.
- Monitor and assess uncertain tax positions and adjust estimates as new information becomes available.
Key Dates
| Date | Description |
|---|---|
| 1998-05-12 | Company incorporated in the State of Nevada. |
| 2018-10-01 | Effective date of Ownership Interest Purchase Agreement for ENP Investments. |
| 2019-01-31 | Company invested in a Florida-based LLC engaged in international sales of fertilizer additives. |
| 2019 | Company redomiciled into Alberta, Canada. |
| 2022 | NanoChem purchased an additional 50% in ENP Peru, increasing its share to 91.67%. |
| 2023 | NanoChem purchased the remaining 8.33% of ENP Peru shares, becoming sole owner. |
| 2023 | Company purchased an 80% interest in 317 Mendota LLC. |
| 2023-12-31 | Balance sheet date for prior year equity method investment in Florida-based LLC. |
| 2024-03-31 | Lease termination in Naperville, IL, incurring a one-time cost. |
| 2024-05-16 | Payment date for $0.10 per share special dividend for Q2 2024. |
| 2024-06-30 | End of prior year's second fiscal quarter. |
| 2024-08-01 | Company entered into a subsequent agreement for the sale of its remaining 19.9% interest in Florida-based LLC. |
| 2024-08-14 | Date of common shares outstanding count (12,656,532 shares). |
| 2024-08-31 | Company sold a 30.1% interest in the Florida-based LLC to a third party for $2,000,000. |
| 2024-08-31 | Renewal date for the line of credit with Stock Yards Bank and Trust for NanoChem. |
| 2024-09 | Maturity date for a term deposit of $752,682. |
| 2024-12-31 | Balance sheet date for prior fiscal year. |
| 2025-01-01 | Effective date for the adoption of ASU 2023-09 (Topic 740) Improvements to Income Tax Disclosures. |
| 2025-01-01 | Start date for annual sale of 3.98% interest in Florida-based LLC for $800,000 payment. |
| 2025-02 | Maturity date for a term deposit of $313,225. |
| 2025-05-19 | Record date for $0.10 per share special dividend for Q2 2025. |
| 2025-05-28 | Payment date for $0.10 per share special dividend for Q2 2025. |
| 2025-06 | Maturity date for NanoChem's 3-year note payable (4.90% interest). |
| 2025-06 | Renewal date for ENP Investments' line of credit with Stock Yards Bank and Trust. |
| 2025-06-30 | End of current fiscal quarter and six-month period. |
| 2025-07 | Interest-only payments through July 2024 for NanoChem's 5-year note payable (6.5% interest). |
| 2025-07-31 | Date 4,000 shares were issued upon exercise of employee stock options. |
| 2025-08 | Maturity date for a term deposit of $320,243. |
| 2025-08-14 | Filing date of the 10-Q report. |
| 2026-12-15 | Effective date for ASU 2024-03 for annual periods beginning after this date. |
| 2027-12-15 | Effective date for ASU 2024-03 for interim periods beginning after this date. |
| 2028-06 | Lump sum payment of $2,024,710 due for 317 Mendota's 5-year note payable. |
| 2029-08 | Maturity date for NanoChem's 5-year note payable (7.0% interest). |
| 2030-01 | Maturity date for ENP Mendota's 10-year mortgage and ENP Peru's 10-year mortgage. |
| 2032-06 | Maturity date for ENP Peru's 10-year mortgage (2nd mortgage). |
Recommendation
holdWhile the significant jump in Q2 net income and gross profit, driven by a new R&D services project, is a positive development, the underlying decline in product sales and the relatively flat net income for the six-month period present a mixed financial picture. The new R&D revenue stream is promising for diversification and higher margins, but its long-term sustainability and ability to consistently offset product sales weakness need further demonstration. Increased interest expenses and decreased operating cash flow are areas of concern. The company appears to be in a transitional phase, with a new revenue stream emerging while traditional product sales face headwinds. A 'hold' recommendation allows investors to observe if the R&D services growth can consistently drive overall profitability and if product sales stabilize or recover, without taking on immediate additional risk or divesting prematurely.
Keywords
Specialty Chemicals, Water Conservation, Biodegradable Polymers, TPAs, Agriculture, Oil and Gas, Fertilizer Additives, Research and Development Services, SEC Filing, Quarterly Report, Financial Results, FSI, Flexible Solutions International
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.